Research shows that elite stocks produce annual earnings growth of 25% or more in each of the past three years. Celgene (CELG) met that standard from 2009 through 2012. The Street thinks that streak will end this year when the company earns an estimated $5.66 per share, which would be a 15% increase. Yet, the Street's estimates aren't always right. How much of a beat would it take to hit 25% EPS growth in 2013? Earnings last year were $4.91 per